Malaria diagnostic and treatment practices for febrile children under 5 years at two general hospitals in Karamoja, a high transmission setting in Uganda.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
03 Nov 2022
Historique:
received: 13 02 2022
accepted: 18 10 2022
entrez: 4 11 2022
pubmed: 5 11 2022
medline: 8 11 2022
Statut: epublish

Résumé

Malaria is one of the leading causes of morbidity and mortality among children under 5 years of age in Uganda. Although Karamoja sub-region has the highest prevalence of malaria, and one of the highest case fatality rates in children under 5 years, information on malaria case management for the sub-region is scarce. The study evaluated the malaria diagnostic and treatment practices, as well as the factors associated with inappropriate care for children under 5 years of age presenting with fever in two public hospitals within the sub-region. A cross-sectional study was conducted amongst 857 children under 5 years of age who presented with fever at Abim and Kaabong general hospitals between February and March 2020. A questionnaire was administered to the primary caregiver during exit/bedside interviews to collect socio-demographic information. The participant clinical notes were reviewed to capture information on laboratory tests conducted, diagnosis given, and treatment prescribed. In addition, a health facility assessment was conducted and information on healthcare workers was collected. The healthcare worker and facility data was linked to the participant's hospital visit. Main outcome measures were malaria diagnostic and treatment practices. Of the 857 children enrolled, 820 (95.7%) had a malaria diagnostic test done and 623 (76.0%) tested positive for malaria. All test positive children received anti-malarial treatment, however, only 424/623 (68.1%) received the recommended anti-malarial drug and 376/424 (88.7%) received the right dose of the treatment. Inappropriate diagnosis/treatment was in 321 (37.5%) of the enrolled participants. Factors associated with inappropriate diagnosis/treatment included: lack of recommended anti-malarials on the day of the visit (Prevalence Ratio [PR] = 2.1, 95% confidence interval [CI] 1.8-2.4), hospital where care was sought (PR = 0.4, 95% CI 0.3-0.5), being managed by a recently supervised health worker (PR = 0.5, 95% CI 0.2-0.9), and health worker cadre (PR = 0.8, 95% CI 0.7-0.9). The prevalence of inappropriate malaria diagnosis and treatment in the Karamoja sub-region was high with approximately one in every three children receiving inappropriate care. This was majorly influenced by health system factors, which if improved upon may reduce malaria-related mortalities in the sub-region a vital step in meeting the country's target of zero deaths from malaria by 2030.

Sections du résumé

BACKGROUND BACKGROUND
Malaria is one of the leading causes of morbidity and mortality among children under 5 years of age in Uganda. Although Karamoja sub-region has the highest prevalence of malaria, and one of the highest case fatality rates in children under 5 years, information on malaria case management for the sub-region is scarce. The study evaluated the malaria diagnostic and treatment practices, as well as the factors associated with inappropriate care for children under 5 years of age presenting with fever in two public hospitals within the sub-region.
METHODS METHODS
A cross-sectional study was conducted amongst 857 children under 5 years of age who presented with fever at Abim and Kaabong general hospitals between February and March 2020. A questionnaire was administered to the primary caregiver during exit/bedside interviews to collect socio-demographic information. The participant clinical notes were reviewed to capture information on laboratory tests conducted, diagnosis given, and treatment prescribed. In addition, a health facility assessment was conducted and information on healthcare workers was collected. The healthcare worker and facility data was linked to the participant's hospital visit. Main outcome measures were malaria diagnostic and treatment practices.
RESULTS RESULTS
Of the 857 children enrolled, 820 (95.7%) had a malaria diagnostic test done and 623 (76.0%) tested positive for malaria. All test positive children received anti-malarial treatment, however, only 424/623 (68.1%) received the recommended anti-malarial drug and 376/424 (88.7%) received the right dose of the treatment. Inappropriate diagnosis/treatment was in 321 (37.5%) of the enrolled participants. Factors associated with inappropriate diagnosis/treatment included: lack of recommended anti-malarials on the day of the visit (Prevalence Ratio [PR] = 2.1, 95% confidence interval [CI] 1.8-2.4), hospital where care was sought (PR = 0.4, 95% CI 0.3-0.5), being managed by a recently supervised health worker (PR = 0.5, 95% CI 0.2-0.9), and health worker cadre (PR = 0.8, 95% CI 0.7-0.9).
CONCLUSION CONCLUSIONS
The prevalence of inappropriate malaria diagnosis and treatment in the Karamoja sub-region was high with approximately one in every three children receiving inappropriate care. This was majorly influenced by health system factors, which if improved upon may reduce malaria-related mortalities in the sub-region a vital step in meeting the country's target of zero deaths from malaria by 2030.

Identifiants

pubmed: 36329454
doi: 10.1186/s12936-022-04329-w
pii: 10.1186/s12936-022-04329-w
pmc: PMC9635090
doi:

Substances chimiques

Antimalarials 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

312

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010526
Pays : United States
Organisme : FIC NIH HHS
ID : K43 TW010365
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW011213
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Malar J. 2008 Sep 19;7:181
pubmed: 18803833
Pan Afr Med J. 2018 Jul 26;30:229
pubmed: 30574247
Malar J. 2021 Apr 15;20(1):187
pubmed: 33858434
Trop Med Int Health. 2009 May;14(5):491-8
pubmed: 19222821
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
Malar J. 2015 Aug 27;14:331
pubmed: 26306395
BMJ. 2004 Nov 20;329(7476):1212
pubmed: 15542534
Glob Health Action. 2016 Dec 16;9:31744
pubmed: 27989273
Malar J. 2013 Sep 21;12:334
pubmed: 24053679
Lancet Infect Dis. 2009 Jul;9(7):448-52
pubmed: 19555904
Malar J. 2012 Feb 13;11:44
pubmed: 22330281
Clin Infect Dis. 2016 Dec 15;63(suppl 5):S276-S282
pubmed: 27941105
Malar J. 2011 May 24;10:144
pubmed: 21609473
Malar J. 2009 Apr 16;8:66
pubmed: 19371426
Am J Trop Med Hyg. 2009 Jun;80(6):919-26
pubmed: 19478249
Malar J. 2017 Jan 23;16(1):40
pubmed: 28114942
PLoS One. 2014 Mar 24;9(3):e92782
pubmed: 24663961
Malar J. 2013 Apr 16;12:131
pubmed: 23587179
Malar J. 2016 Feb 24;15:112
pubmed: 26911252
Malar J. 2016 Jan 11;15:23
pubmed: 26754484
BMJ. 2009 Jul 21;339:b2763
pubmed: 19622553
Afr Health Sci. 2004 Apr;4(1):50-7
pubmed: 15126192
Acta Trop. 2012 Mar;121(3):184-95
pubmed: 21420377
Malar J. 2011 Apr 29;10:107
pubmed: 21529365
BMC Public Health. 2016 Aug 19;16(1):828
pubmed: 27538947

Auteurs

Jane Frances Zalwango (JF)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. zalwangojanefrances@gmail.com.

Joaniter I Nankabirwa (JI)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Infectious Diseases Research Collaboration, Kampala, Uganda.

Freddy Eric Kitutu (FE)

Department of Pharmacy, School of Health Sciences, Makerere University, Kampala, Uganda.
Sustainable Pharmaceutical Systems (SPS) Unit, School of Health Sciences, Makerere University, Kampala, Uganda.

Rebecca Akunzirwe (R)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Remmy Buhuguru (R)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Joan Bayowa Rokani (JB)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Emmanuel Ssendikwanawa (E)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Sarah Kiguli (S)

Department of Pediatrics and Child Health, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Emmanuel Arinaitwe (E)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Joan N Kalyango (JN)

Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Department of Pharmacy, School of Health Sciences, Makerere University, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH